Tubo-ovarian Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Tubo-ovarian Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (3 shown)

Not Yet RecruitingNot Applicable

NCT06726330

Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Ca…

• FIMBRIMENOP-2402 study aims to evaluate the long-term management of cancer risks in premenopausal women who have a genetic predisposition to tubo-ovarian or p…

France1,100 participantsStarted 2027-03

Treatment: Fimbriectomy Followed by Delayed Oophorectomy (F-DO), Bilateral Salpingo-Oophorectomy

CompletedPhase 2

NCT00679783

Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients…

This is a Phase II, open label, non randomized correlative study of AZD2281 in patients with recurrent breast and ovarian cancer in both BRCA inherited mutation…

Canada99 participantsStarted 2008-07-08

Treatment: AZD2281

CompletedNot Applicable

NCT05204342

Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France

Evaluation of the following prognostic factors in France, based on national quotation data: volume per center, patient age, geographic distance from a clinical…

France22,500 participantsStarted 2012-01-01